24 Nov An Update in the Management of Cancer-Associated Thrombosis – Webinar
Posted at 10:53h
in
November 23, 2022...
Archive
22 Nov Management of an Acute Bleed in ITP
Posted at 15:44h
in
Author: Dr. Barbara Gunka, McMaster UniversityReviewers: Dr. Siraj Mithoowani and Dr. Wendy Lim, McMaster UniversityLearning Objectives:As the end of this self-assessment module, participants should be able to:Identify situations in which outpatient management of bleeding in ITP may be appropriate Understand how severity of bleeding...
22 Nov Latest BYKi Data for CLL and its impact on Cardio-Oncology Clinical Practice – 10/6/2022 Webinar
Posted at 10:08h
in
13 Oct Management of ITP in Pregnancy
Posted at 15:59h
in
Author: Dr. Barbara GunkaReviewer: Dr. Siraj Mithoowani, Assistant Professor, Dept of Medicine, McMaster University Objectives At the end of the self-assessment module, participants will be able to:Describe the management of ITP during pregnancy Identify platelet count thresholds for administering neuraxial anesthesia in ITP Discuss risk factors...
13 Oct Fostamatinib in Chronic ITP
Posted at 15:34h
in
Author: Dr. Farid Azadian, University of OttawaReviewer: Dr. Siraj Mithoowani, Assistant Professor, Dept of Medicine, McMaster University Objectives At the end of the self-assessment module, participants will be able to:Describe first and second-line therapies for immune thrombocytopenia Describe the mechanism of action and clinical efficacy of...
06 Oct Use of Immune Checkpoint Inhibitors in Lymphoma – 9/20/22 Webinar
Posted at 15:13h
in
06 Oct Anticoagulation in patients with Covid-19 infections – 10/5/2022 Webinar
Posted at 15:09h
in
13 Jul Clinical Cases to Enhance Knowledge – For Patients with Chronic Lymphocytic Leukemia – Webinar
Posted at 10:20h
in
12 Jul Low Risk MDS
Posted at 16:26h
in
Author: Dr. Stefan D. JevticReviewer: Dr. Dina Khalaf Objectives At the end of the self-assessment module, participants will be able to:Describe an approach to the initial management approach of patients with lower-risk MDS Discuss the common adverse effects of erythroid-maturation agents in patients on this therapy...